Nohla Therapeutics
Nohla Therapeutics is a Seattle-based therapeutics company that Ben Bergo previously co-founded.
Facts
- HQ
- Seattle
- Sectors
- Biotech, Therapeutics
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Seattle’s Deverra Therapeutics Raises $2.4M to Develop Cellular Immunotherapies with Fred Hutch License
Seattle biotech startup Deverra Therapeutics, founded by oncologist Colleen Delaney, is raising $2.4 million through debt and warrants to advance its cellular immunotherapy platform licensed from Fred Hutch. The company recently secured $3.5 million from the Andy Hill CARE Fund and licensed an immuno-oncology platform from Coeptis Therapeutics for $570,000 plus shares.
Visus Therapeutics raises $20M to advance BRIMOCHOL presbyopia eye drop after $36M round six months earlier
Seattle startup Visus Therapeutics raised $20 million to develop BRIMOCHOL, a once-daily eye drop intended to treat presbyopia, following a $36 million raise six months earlier.
Visus Therapeutics raises $36M Series A from Johnson & Johnson Innovation, RTW Investments and others to advance BRIMOCHOL presbyopia eye drop
Visus Therapeutics, a Seattle startup developing BRIMOCHOL, a once-daily presbyopia-correcting eye drop, raised $36 million in a Series A led in part by Johnson & Johnson Innovation alongside RTW Investments, Wille AG and existing investors.
Questions about Nohla Therapeutics
What is Nohla Therapeutics?
Seattle
Who invested in Nohla Therapeutics, and how much has it raised?
Members of Seattle Flow see Nohla Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Nohla Therapeutics based?
Nohla Therapeutics is headquartered in Seattle.